Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2541 – 2560 of 3231

Immunizations for Preventable Diseases in Children and Adolescents With HIV

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/immunizations-for-preventable-diseases

Stavudine (Zerit, d4T)

https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-stavudine-zerit

Efavirenz (EFV)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-efavirenz-sustiva

Appendix C. Panel Members

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/appendix-panel-roster

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/elvitegravir

Cryptosporidiosis

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/cryptosporidiosis

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/raltegravir

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/histoplasmosis

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/chagas-disease

Drug-Drug Interactions: CCR5 Antagonist and Other Drugs

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-ccr5-antagonist

Ibalizumab-uiyk (Trogarzo, IBA)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-entry-attachment-inhibitors-ibalizumab-uiyk-trogarzo

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/darunavir

Antiretroviral Management of Infants With In Utero, Intrapartum, or Breastfeeding Exposure to HIV

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/management-infants-utero-intrapartum-breastfeeding-hiv-exposure

Human Papillomavirus Disease

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/human

Appendix C: Antiretroviral Medications That Can Be Switched Temporarily If Unable to Access Certain Formulations

https://clinicalinfo.hiv.gov/guidelines/guidance-hiv-disasters/appendix-antiretroviral-medications-switched-temporarily

Maraviroc (Selzentry, MVC)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-entry-attachment-inhibitors-maraviroc-selzentry

Disseminated Mycobacterium avium Complex Disease

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/disseminated

Mycobacterium avium Complex Disease

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/mycobacterium-avium-complex

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/fosamprenavir

Varicella-Zoster Virus Disease

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/varicella-zoster-virus